A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2001
11/01/2001	WO2001080902A2 A particulate complex for administering nucleic acid into a cell
11/01/2001	WO2001080900A2 Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane
11/01/2001	WO2001080899A2 Rhamm peptide conjugates
11/01/2001	WO2001080898A1 Fullerene-based drugs targeted to bone
11/01/2001	WO2001080897A2 Compositions and methods for in vivo delivery of polynucleotide-based therapeutics
11/01/2001	WO2001080865A2 Joint repair using mesenchymal stem cells
11/01/2001	WO2001080858A1 Stable liquid preparation
11/01/2001	WO2001080850A1 Urea-containing gel preparation
11/01/2001	WO2001080840A2 Cytotoxic agents comprising single-stranded and/or looped dna
11/01/2001	WO2001080836A1 Use of particulate vectors in immunomodulation
11/01/2001	WO2001080835A1 Process for producing microsphere
11/01/2001	WO2001080834A1 Composition
11/01/2001	WO2001080833A1 Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
11/01/2001	WO2001080832A2 Administration of a thiol-based chemoprotectant compound
11/01/2001	WO2001080831A2 Zero order release and temperature-controlled microcapsules and process for the preparation thereof
11/01/2001	WO2001080829A2 Taste masking coating composition
11/01/2001	WO2001080828A2 Improved water-insoluble drug particle process
11/01/2001	WO2001080823A2 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients
11/01/2001	WO2001080822A2 Effervescent granules and methods for their preparation
11/01/2001	WO2001080819A1 Cosmetic or dermatological cream composition, the preparation and the use thereof
11/01/2001	WO2001080817A1 Dextranase-containing oral care compositions
11/01/2001	WO2001080796A1 Minimizing adverse experience associated with oxybutynin therapy
11/01/2001	WO2001080619A2 Pharmaceutical composition containing citalopram
11/01/2001	WO2001042231A3 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors
11/01/2001	WO2001041762A3 Valdecoxib compositions
11/01/2001	WO2001041761A3 Valdecoxib compositions
11/01/2001	WO2001036609A8 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
11/01/2001	WO2001036608A8 Reversibly inactivated acidified plasmin
11/01/2001	WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001	WO2001029046A3 A salt of morphine
11/01/2001	WO2001014318A3 New effectors of dipeptidyl peptidase iv for topical use
11/01/2001	WO2001013924A8 Novel compositions for controlled release of a biologically active agent, and the preparation thereof
11/01/2001	WO2001012233A3 Sustained release formulation of a peptide
11/01/2001	WO2000044333A3 Novel injectable antimalarial compositions of artemisinin
11/01/2001	WO1999013816A3 Liposomal camptothecin formulations
11/01/2001	US20010037080 Photoatherolytic catheter apparatus and method
11/01/2001	US20010037006 Introducing monomeric 2-hydroxyethyl methacrylate containing ethylene glycol dimethacrylate impurities in the range of 0.05 to 0.1% by weight with hydroxybutyl acrylate into a solution of water and alcohol, copolymerizing; gel-free
11/01/2001	US20010036966 Hardly soluble drug together with water-soluble polymer; does not undergo aggregation of dispersed particles or caking; useful as a parenteral preparation, eye drops, nasal drops
11/01/2001	US20010036962 Self-emulsifying systems containing anticancer medicament
11/01/2001	US20010036960 Carvedilol-lipophilic solutions
11/01/2001	US20010036959 Carvedilol-hydrophilic solutions
11/01/2001	US20010036948 Administering a vascular alkylating compound; prevention restenosis
11/01/2001	US20010036933 Water soluble lipidated arabinogalactan
11/01/2001	US20010036930 Therapeutic azide compounds
11/01/2001	US20010036927 Complexing
11/01/2001	US20010036924 Dietetics, immunomodulator, antiinflammatory agents
11/01/2001	US20010036920 Method for treating papillomavirus infections
11/01/2001	US20010036918 Pharmaceutical composition
11/01/2001	US20010036916 Insoluble insulin compositions
11/01/2001	US20010036898 Activating catalyst; reducing by-products
11/01/2001	US20010036635 Cancer screening
11/01/2001	US20010036500 For enriching foods or beverages, anemia treatment
11/01/2001	US20010036487 Proanthocyanidin-containing composition
11/01/2001	US20010036483 Administering drug to localized region of human patient's body surface in combination with hydroxide releasing agent applied to body surface
11/01/2001	US20010036482 Antimicrobial compositions for mastitis control
11/01/2001	US20010036481 Modulation of release from dry powder formulations
11/01/2001	US20010036477 Oral administering
11/01/2001	US20010036476 Bioavailability; sustained release
11/01/2001	US20010036475 Pharmaceutical tablets
11/01/2001	US20010036473 Enteric and colonic delivery using HPMC capsules
11/01/2001	US20010036472 Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
11/01/2001	US20010036471 Hard capsules comprising polymers of vinyl esters and polyethers, their use and production
11/01/2001	US20010036463 Transcutaneous immunization for large particulate antigens
11/01/2001	US20010036450 Oil in water emulsions
11/01/2001	US20010036449 Therapy for dry eye
11/01/2001	US20010036444 Anticancer agents
11/01/2001	CA2690018A1 Methods and compositions for the prevention and treatment of anemia
11/01/2001	CA2407515A1 A particulate complex for administering nucleic acid into a cell
11/01/2001	CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001	CA2407448A1 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals
11/01/2001	CA2407154A1 Zero order release and temperature-controlled microcapsules and process for the preparation thereof
11/01/2001	CA2407074A1 Compositions and methods for in vivo delivery of polynucleotide-based therapeutics
11/01/2001	CA2406949A1 Use of particulate vectors in immunomodulation
11/01/2001	CA2406654A1 Methods of enhancing splp-mediated transfection using endosomal membrane destabilizers
11/01/2001	CA2406593A1 Rhamm peptide conjugates
11/01/2001	CA2405194A1 Process for producing microspheres
11/01/2001	CA2404998A1 Cytotoxic agents
11/01/2001	CA2345501A1 Anhydrous topical skin preparations
10/2001
10/31/2001	EP1149913A1 Cytokine immunoconjugates
10/31/2001	EP1149117A1 Novel alkanolamide-free thickening latex
10/31/2001	EP1149116A1 Process for the production of multiple cross-linked hyaluronic acid derivatives
10/31/2001	EP1149115A1 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41
10/31/2001	EP1149080A2 Crystalline form of benzoquinoline-3-one derivative as inhibitor of 5-alpha reductase
10/31/2001	EP1149066A1 Method of preparing alkylated salicylamides
10/31/2001	EP1148905A2 Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols suitable therefor
10/31/2001	EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001	EP1148895A1 Thermo-reversible polymer for intralumenal implant
10/31/2001	EP1148875A1 Methods and compositions to enhance white blood cell count
10/31/2001	EP1148871A1 Core tablet for controlled release of gliclazide after oral administration
10/31/2001	EP1148870A1 Anti-plaque emulsions and products containing same
10/31/2001	EP1148864A1 Hair treatment compositions comprising c20 or higher unsaturated fatty acid polyester of cyclic polyols
10/31/2001	EP1148793A1 Method of preparing microparticles of phytosterols or phytostanols
10/31/2001	EP1058540B1 Oral pellet with immediate release comprising glycerides subjected to polyglycolysis, method for making same
10/31/2001	EP1054945B1 Use of detergent mixtures as solutizers
10/31/2001	EP1001799B1 Pharmaceutical composition containing peptichemio
10/31/2001	EP0966291B1 Medicinal preparation containing a lipophilic inert gas
10/31/2001	EP0894043B1 Method of forming articles and patterning surfaces via capillary micromolding
10/31/2001	EP0809486B1 Bio-erodible ophthalmic shield
10/31/2001	EP0759760B1 Wound healing agent
10/31/2001	EP0716598B1 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa

1 ... 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 ... 1712